Clomipramine

ANAFRANIL

Tricyclic Antidepressant

NADAC/unit $0.2029

No Shortage Tier 1: 59.3% PA Req: 94.8% 13 Manufacturers 39 ANDAs

Clomipramine treats depression and chronic pain by blocking reuptake of serotonin and norepinephrine.

vs. brand ANAFRANIL: Generic saves up to 98% per unit

Covered Lives

Market Intelligence

2025-11-12 Class II Recall: Zydus Pharmaceuticals (USA) Inc

Generic Manufacturers

ALEMBIC PHARMACEUTICALS LTDAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCIXORA LIFESCIENCE LLPJUBILANT CADISTA PHARMACEUTICALS INCLUPIN LTDMANKIND PHARMA LTDMICRO LABS LTDSANDOZ INCSPECGX LLCTARO PHARMACEUTICAL INDUSTRIES LTDTP ANDA HOLDINGS LLCUNIQUE PHARMACEUTICAL LABORATORIES A DIV OF JB CHEMICALS AND PHARMACEUTICALS LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Clomipramine drfinder.aiFind doctors who prescribe Clomipramine clinicalrx.aiClinical profile: Clomipramine rxnews.aiLatest news about Clomipramine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.